Sanofi FY 2012 - Interview with CEO Chris Viehbacher

  Sanofi FY 2012 - Interview with CEO Chris Viehbacher

Business Wire

PARIS -- February 7, 2013

Sanofi, a global and diversified healthcare leader, reports 2012 results. CEO
Chris Viehbacher comments on 2012 results and outlook for 2013.

Click to watch the video: http://bit.ly/XkZjhU

Topics covered in the interview include:

- 2012 Results
- Genzyme
- Emerging Markets
- Diabetes franchise
- R&D Pipeline
- Animal Health
- Capital Allocation
- Cost savings
- 2013 Guidance

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients’ needs. Sanofi has core
strengths in the field of healthcare with seven growth platforms: diabetes
solutions, human vaccines, innovative drugs, consumer healthcare, emerging
markets, animal health and the new Genzyme. Sanofi is listed in Paris
(EURONEXT: SAN) and in New York (NYSE: SNY).

Company website: www.sanofi.com

Contact:

Sanofi
Investor Relations:
Sébastien Martel, +33 1 53 77 45 45
IR@sanofi.com
or
Media Relations:
+33 1 53 77 45 02
MR@sanofi.com
 
Press spacebar to pause and continue. Press esc to stop.